BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

KaloBios Pharmaceuticals, Inc. 

260 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-243-3100 Fax: 650-243-3260


SEARCH JOBS




Industry
Biotechnology






 Company News
KaloBios Pharmaceuticals, Inc. (KBIO) Appoints Ronald A. Martell Executive Chairman 5/29/2015 7:05:39 AM
KaloBios Pharmaceuticals, Inc. (KBIO) Reports First Quarter 2015 Financial Results 5/11/2015 7:05:57 AM
KaloBios Pharmaceuticals, Inc. (KBIO) Elects Ronald A. Martell To Board Of Directors 4/23/2015 10:53:20 AM
KaloBios Pharmaceuticals, Inc. (KBIO) To Present At The 14th Annual Needham Healthcare Conference 4/6/2015 8:24:16 AM
KaloBios Pharmaceuticals, Inc. (KBIO) Announces Upcoming Investor Conference Participation 2/4/2015 11:05:59 AM
Bay Area's KaloBios Pharmaceuticals, Inc. (KBIO) Terminates 20% of Workforce, Including the CMO 2/3/2015 6:19:01 AM
KaloBios Pharmaceuticals, Inc. (KBIO) Announces Retirement Of David W. Pritchard, President And Chief Executive Officer 1/9/2015 7:40:47 AM
KaloBios Pharmaceuticals, Inc. (KBIO) Reports Top-Line Data For Phase 2 Study Of KB001-A To Treat Pseudomonas Aeruginosa Lung Infections In Cystic Fibrosis Patients 1/7/2015 6:04:16 AM
KaloBios Pharmaceuticals, Inc. (KBIO) Announces Upcoming Scientific And Investor Conference Participation 11/12/2014 7:45:47 AM
KaloBios Pharmaceuticals, Inc. (KBIO) Reports Third Quarter Financial Results 11/7/2014 8:03:56 AM
123456789